Chapter 763: Technical Exchange
"Dr. Hanson, excuse me for interrupting," Valerie said softly, standing at the doorway.
Dr. Hanson looked up and saw Valerie, a faint smile appearing on her face. "Miss Valerie, please come in. Perfect timing; I just finished a set of preliminary observations."
Valerie walked into the laboratory, her gaze sweeping over the crude equipment. Just as Dr. Hanson had mentioned before, the conditions here were indeed quite basic.
"I hope I haven't interrupted your important work," Valerie said.
"Not at all. Just basic observations." Dr. Hanson straightened up, rubbing the back of her slightly sore neck. "The activity of these spores is already very low, and they have a hard time surviving after environmental changes. What would truly be valuable are live samples, but the Hyperion lacks safe conditions for live cultivation."
Her tone carried obvious regret.
Valerie nodded and handed over the data-slate she was holding.
"Doctor, this is the summary of some biotechnological methods used internally by our company that I mentioned earlier. It has been sanitized and does not involve core patents, but it might provide some different perspectives for your research."
Dr. Hanson's eyes immediately lit up. She took the data-slate almost eagerly, quickly waking up the screen to browse.
At first, her expression was one of focused review, but as she read deeper, her brows would sometimes furrow and sometimes relax; occasionally, she would mutter a few words to herself.
"This genetic sequence alignment algorithm... employs multiple fuzzy matching and probabilistic weighting? The concept is very unique, completely different from the precise chain alignment commonly used in the Koprulu Sector. It sacrifices a certain degree of absolute precision, but in exchange, it gains a higher fault tolerance and recognition speed for highly mutated sequences... interesting."
"Protein folding simulation... introducing environmental charge gradient variables as auxiliary parameters? In our general models, this is usually eliminated as an interference term. But thinking about it carefully, the intracellular environment is indeed not homogenous... this is a bold hypothesis."
"Nanofiber scaffolds... utilizing electrospinning technology to manufacture biomimetic extracellular matrices? The material selection is... a composite of synthetic polyester and natural gelatin? How was the balance point between mechanical strength and biocompatibility for this combination found?"
Dr. Hanson was completely immersed in the technical documents, sometimes swiping through pages quickly, and sometimes stopping to think carefully.
Her two assistants also leaned over curiously to look, letting out low gasps of amazement.
Valerie stood quietly to the side, observing Dr. Hanson's reactions.
This female scientist clearly possessed an extremely high level of professional expertise, able to quickly understand the principles and potential value of these technologies, and immediately compare and question them against the systems she knew.
About twenty minutes later, Dr. Hanson finally looked up from the data-slate, letting out a long breath.
Her face bore an expression mixed with excitement, confusion, and deep thought.
"Miss Valerie," her voice was somewhat agitated, "these technological concepts... are incredibly novel. No, not just novel, their underlying hypotheses and problem-solving methodologies have significant differences from the mainstream biotechnology of the Koprulu Sector."
She pointed to a chart on the data-slate: "For example, this rapid genetic sequencing algorithm, it seems to be based on an entirely different mathematical and logical framework. On our end, we focus more on 'correctness,' where every step must be verifiable and repeatable. Your method... is more like searching for the 'most probable' among 'possibilities,' allowing for a certain degree of fuzziness and uncertainty in exchange for speed. This requires extremely powerful data processing capabilities as support."
She pointed to another section: "And this cell culture scaffold, the way material science and bioengineering are combined is also very unique. We tend to lean towards using pure biological materials or highly refined synthetic materials to ensure absolute controllability. Your composite material approach seems rough, but the design concept is to simulate the non-homogenous characteristics of natural tissues... this requires very precise process control and a profound understanding of biological micro-environments."
Dr. Hanson put down the data-slate, her gaze burning as she looked at Valerie: "These are not just some 'practical technologies.' They represent a different scientific research paradigm behind them. Has the biotechnology of the Earth Sphere already developed to this level? Or is this a research achievement unique to 'Far Star United'?"
Valerie maintained a calm smile.
"You flatter me, Doctor. These are just some phased results from the company's R&D department, far from representing the technological level of the Earth Sphere. Just as you said, the two sectors have been isolated for too long and have developed different technological paths. Our methods might be effective in certain specific scenarios, but in other aspects, the solid, practical technology of the Koprulu Sector might hold more advantages."
She cleverly avoided directly answering the question about the Earth Sphere's overall level, pulling the focus back to the technology itself. "Are these materials helpful for your research?"
"Immensely helpful!" Dr. Hanson affirmed. "They provide entirely new lines of thought. Especially regarding research approaches for dealing with highly mutated organisms. The genetic stability of the Swarm is extremely poor, and their mutation rate is fast. Our traditional analysis methods frequently encounter difficulties. Your alignment algorithm with a higher fault tolerance might be able to better process the genetic data of Swarm samples."
She paused, her tone becoming somewhat hesitant, but mostly eager: "Miss Valerie, these technologies... are there more detailed implementation specifics or experimental data? Of course, I understand this involves corporate secrets. But if possible, even just a small portion of more in-depth information would greatly propel my research. I can sign any non-disclosure agreement."
Valerie's heart stirred slightly. Dr. Hanson had already shown strong interest and an eagerness to learn more. This was exactly a good opportunity to establish a closer connection.
"More detailed materials do indeed require a higher level of authorization." Valerie showed a hint of difficulty but a willingness to try. "However, Doctor, your research directly contributes to combating the Swarm, which aligns with our company's principle of 'Risk Mitigation and Cooperation.' I can try applying to headquarters to retrieve some non-core expanded materials or case analyses. But this will take time, and it will also require... a clearer cooperation framework."
Dr. Hanson nodded immediately.
"I understand. I am willing to seriously consider any form of cooperation. If your company is interested in Swarm research, I can share some of my research findings—of course, excluding the core secrets of my past work for the Dominion. We can conduct a technical exchange, complementing each other's strengths and weaknesses."
This was exactly the situation Valerie hoped to achieve.
"I will report your intentions to headquarters as soon as possible, Doctor. I believe the higher-ups will be interested in cooperating with an expert like yourself."